Clinical Trial Update: A Trial of HRS-9813 in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating HRS-9813 in healthy subjects, sponsored by Guangdong Hengrui Pharmaceutical, with listed conditions including Idiopathic Pulmo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis
• Progressive Pulmonary Fibrosis

Drugs mentioned

• HRS-9813

Snippet

Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd | Conditions: Idiopathic Pulmonary Fibrosis/Progressive Pulmonary Fibrosis | Phase 1 | Status: RECRUITING